ITGAX and neoplasm: Tumor-infiltrating CD11c+ DCs isolated from VV-treated MC38 tumors were pulsed with neopeptides 4 (dominant), 9, and 11 (subdominant), and then cocultured with neoantigens-primed T cells isolated from mice immunized with the 11 neoepitope peptides mixture formulated with adjuvants.